Mark Newman

Mark Newman is a seasoned life science industry strategist with a diverse background in corporate strategy, early stage drug development, business development, financial modeling, and commercial strategy.

His experience includes leading teams and initiatives, fostering relationships, and influencing senior leadership to drive positive changes and important impacts within the industry.

Mark Newman is particularly passionate about introducing innovative products to the market to enhance the lives of patients.

He pursued his education at Riverdale Country Day School for his early studies, earned a Bachelor of Arts (BA) from Bowdoin College, and completed his Master of Business Administration (MBA) at Stanford University Graduate School of Business.

Currently, Mark Newman serves as the Director of Business Development at Maze Therapeutics.